69
Views
4
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

A prognostic scoring system for adult patients less than 60 years of age with acute lymphoblastic leukemia in first relapse

, , , , , , , & show all
Pages 1126-1131 | Received 12 Feb 2009, Accepted 09 Apr 2009, Published online: 21 Jul 2009

References

  • Vitale A, Guarini A, Chiaretti S, Foa R. The changing scene of adult acute lymphoblastic leukemia. Curr Opin Oncol 2006; 18: 652–659
  • Fielding A K, Richards S M, Chopra R, et al. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL): an MRC UKALL12/ECOG 2993 study. Blood 2007; 109: 944–950
  • Weinberg J B, Volkheimer A D, Chen Y, Beasley B E, Jiang N, Lanasa M C. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia. Am J Hematol 2007; 82: 1063–1070
  • Keating M J, Kantarjian H, Smith T L, et al. Salvage therapy and survival after relapse in acute myelogenous leukemia. J Clin Oncol 1989; 7: 1071–1080
  • Hoelzer D, Theil E, Loffler H, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123–131
  • Wetzler M, Dodge R K, Mrozek K, et al. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood 1999; 93: 3983–3993
  • Cortes J, O'Brien S M, Pierce S, Keating M J, Freireich E J, Kantarjian H M. The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia. Blood 1995; 86: 2091–2097
  • Wiernik P H, Dutcher J P, Paietta E, et al. Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD, a non-anthracycline-containing regimen. Leukemia 1993; 7: 1236–1241
  • Csako G, Magrath I T, Elin R J. Serum total and isoenzyme lactate dehydrogenase activity in American Burkitt's lymphoma patients. Am J Clin Pathol 1982; 78: 712–717
  • Goldstone A H, Richards S M, Lazarus H M, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from matched sibling allogeneic transplantation in first complete remission, and autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008; 111: 1827–1833

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.